← Back to all trials
Completed
NCT05700851
Immuno-nutrition Supplementation in Haemodialysis
Conditions: Chronic Kidney Disease Requiring Chronic Dialysis
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 15
Sponsor: University of Nottingham
Location: United Kingdom
Summary
The purpose of this pilot study is to test if an "immuno-nutrition" supplement can decrease inflammation in people on haemodialysis.
This immuno-nutrition supplement is high in calories and protein like other common nutritional supplements, but also contains a unique combination of ingredients that have been shown to reduce inflammation (a problem which is caused by the body's defence [immune] system communicating that something is wrong) and improve the immune system in people with cancer.
The research team hopes that this small study will help with gaining a good understanding of the effect of immuno-nutrition on inflammation in people on haemodialysis, which will guide and allow the research team to do a larger research study in the future.
Eligibility Criteria
Inclusion Criteria:CRP level >5.0 mg/L.At least three haemodialysis sessions per week for ≥3 hours using a biocompatible dialyser.Able to give informed consent.Exclusion Criteria:Treatment with drugs that cause immunosuppression.Non-English speakers or those with special communication needs.Pregnancy, breast feeding or intending pregnancy.Expected survival <6 months.Hospitalisation at the time of screening.Known intolerance or allergy to ONS (or isolated ingredients).Pre-dialysis serum potassium >5.0 mmol/L.Unable to provide informed consent.
Source: ClinicalTrials.gov (NCT05700851). StuddyBuddy aggregates publicly available trial information.
